Skip to main content
Log in

Clinical results after biliary drainage by endoscopic retrograde cholangiopancreatography for analysis of metastatic cancer survival and prognostic factors

  • Published:
Surgical Endoscopy Aims and scope Submit manuscript

Abstract

Background

Malignant biliary obstruction secondary to metastatic cancer is associated with poor prognosis. To the best of our knowledge, no previous study has investigated long-term survival and associated prognostic factors after biliary endoscopic retrograde cholangiopancreatography (ERCP) drainage for obstruction jaundice secondary to various types of metastatic cancer.

Methods

This retrospective study included 60 patients who underwent biliary ERCP drainage for obstructive jaundice secondary to metastatic cancer at two hospitals during the period from November 2012 to December 2019. Multivariate analysis was conducted to identify independent prognostic factors.

Results

Biliary drainage was successfully achieved in 55 (91.7%) patients, 37 of whom received subsequent treatment. Overall median survival time was 133 days after stent placement. The overall survival (OS) rates after ERCP drainage were significantly better in the post-drainage treatment group than in the post-drainage untreated group (239 days vs. 45 days, p < 0.001). Good ECOG performance status before drainage, albumin level ≥ 35 g/L, successful drainage, absence of ascites, and post-drainage treatment were identified as factors of improved survival in univariate analysis. ECOG performance status and post-drainage treatment were independent predictors of OS in multivariate analysis.

Conclusions

We showed that stent placement with ERCP was a safe and effective treatment method for patients with malignant biliary obstruction caused by metastatic cancer and may be preferred over percutaneous transhepatic biliary drainage. Post-drainage treatment and a good ECOG performance status were predictors of better prognosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Migita K, Watanabe A, Yoshioka T et al (2009) Clinical outcome of malignant biliary obstruction caused by metastatic gastric cancer. World J Surg 33:2396–2402

    Article  Google Scholar 

  2. Gwon DI, Ko GY, Sung KB et al (2012) Clinical outcomes after percutaneous biliary interventions in patients with malignant biliary obstruction caused by metastatic gastric cancer. Acta Radiol 53:422–429

    Article  Google Scholar 

  3. Hong HP, Seo TS, Cha IH et al (2013) Percutaneous placement of self-expandable metallic stents in patients with obstructive jaundice secondary to metastatic gastric cancer after gastrectomy. Korean J Radiol 14:789–796

    Article  Google Scholar 

  4. Sellier F, Bories E, Sibertin-Blanc C et al (2018) Clinical outcome after biliary drainage for metastatic colorectal cancer: survival analysis and prognostic factors. Dig Liver Dis 50:189–194

    Article  Google Scholar 

  5. Nichols SD, Albert S, Shirley L et al (2014) Outcomes in patients with obstructive jaundice from metastatic colorectal cancer and implications for management. J Gastrointest Surg 18:2186–2191

    Article  Google Scholar 

  6. Chaudhari D, Khanna A, Goenka P, Young M (2014) Lung carcinoma presenting as an obstructive jaundice: case series with literature review. J Gastrointest Cancer 45(Suppl 1):66–70

    Article  Google Scholar 

  7. Nakazawa K, Tamura T, Sato S et al (2013) Obstructive jaundice as recurrence of lung adenocarcinoma. J Gastrointest Cancer 44:248–249

    Article  Google Scholar 

  8. Yu CZ, Yu CH, Nai C, Tian J (2015) A presenting with obstructive jaundice in pulmonary adenocarcinoma: a case report. Int J Clin Exp Med 8:11613–11616

    PubMed  PubMed Central  Google Scholar 

  9. Lin Y, Wong SI, Wang Y et al (2019) Periampullary Metastases from breast cancer: a case report and literature review. Case Rep Oncol Med 2019:1–6

    Google Scholar 

  10. Karakatsanis A, Vezakis A, Fragulidis G et al (2013) Obstructive jaundice due to ampullary metastasis of renal cell carcinoma. World J Surg Oncol 11:262

    Article  Google Scholar 

  11. Takasaki Y, Irisawa A, Shibukawa G et al (2018) A case of obstructive jaundice caused by metastasis of ovarian cancer to the duodenal major papilla. Clin Med Insights Case Rep 11:1–4

    Article  Google Scholar 

  12. Ahmmad E, Abdulkarim AS, Dirweesh A (2019) Peri-ampullary metastasis from endometrial adenocarcinoma: a rare etiology of obstructive jaundice. Gastroenterology Res 12:37–39

    Article  Google Scholar 

  13. Dumonceau JM, Tringali A, Papanikolaou IS et al (2018) Endoscopic biliary stenting: indications, choice of stents, and results: European Society of Gastrointestinal Endoscopy (ESGE) Clinical Guideline—Updated October 2017. Endoscopy 50:910–930

    Article  Google Scholar 

  14. Afshar M, Khanom K, Ma YT, Punia P (2014) Biliary stenting in advanced malignancy: an analysis of predictive factors for survival. Cancer Manag Res 6:475–479

    Article  Google Scholar 

  15. Kasuga A, Ishii H, Ozaka M et al (2012) Clinical outcome of biliary drainage for obstructive jaundice caused by colorectal and gastric cancers. Jpn J Clin Oncol 42:1161–1167

    Article  Google Scholar 

  16. Meller MT, Arts GR, Dean JR (2010) Outcomes in percutaneous stenting of non-hepato-biliary/pancreatic malignant jaundice. Eur J Cancer Care (Engl) 19:664–668

    Article  CAS  Google Scholar 

  17. Inamdar S, Slattery E, Bhalla R et al (2016) Comparison of adverse events for endoscopic vs percutaneous biliary drainage in the treatment of malignant biliary tract obstruction in an inpatient national cohort. JAMA Oncol 2:112–117

    Article  Google Scholar 

  18. Wang L, Lin N, Xin F et al (2019) A systematic review of the comparison of the incidence of seeding metastasis between endoscopic biliary drainage and percutaneous transhepatic biliary drainage for resectable malignant biliary obstruction. World J Surg Oncol 17:116

    Article  Google Scholar 

  19. Chapman WC, Sharp KW, Weaver F, Sawyers JL (1989) Tumor seeding from percutaneous biliary catheters. Ann Surg 209:708–713

    Article  CAS  Google Scholar 

  20. Teoh AYB, Dhir V, Kida M et al (2018) Consensus guidelines on the optimal management in interventional EUS procedures: results from the Asian EUS group RAND/UCLA expert panel. Gut 67:1209–1228

    Article  Google Scholar 

  21. Makino T, Fujitani K, Tsujinaka T et al (2008) Role of percutaneous transhepatic biliary drainage in patients with obstructive jaundice caused by local recurrence of gastric cancer. Hepatogastroenterology 55:54–57

    PubMed  Google Scholar 

  22. Wainberg ZA, Feeney K, Lee MA et al (2020) Meta-analysis examining overall survival in patients with pancreatic cancer treated with second-line 5-fluorouracil and oxaliplatin-based therapy after failing first-line gemcitabine-containing therapy: effect of performance status and comparison with other regimens. BMC Cancer 20:633

    Article  CAS  Google Scholar 

  23. Sargent DJ, Kohne CH, Sanoff HK et al (2009) Pooled safety and efficacy analysis examining the effect of performance status on outcomes in nine first-line treatment trials using individual data from patients with metastatic colorectal cancer. J Clin Oncol 27:1948–1955

    Article  Google Scholar 

  24. Lee J, Lim T, Uhm JE et al (2007) Prognostic model to predict survival following first-line chemotherapy in patients with metastatic gastric adenocarcinoma. Ann Oncol 18:886–891

    Article  CAS  Google Scholar 

  25. Tringali A, Hassan C, Rota M et al (2018) Covered vs. uncovered self-expandable metal stents for malignant distal biliary strictures: a systematic review and meta-analysis. Endoscopy 50:631–641

    Article  Google Scholar 

  26. Almadi MA, Barkun A, Martel M (2017) Plastic vs. Self-expandable metal stents for palliation in malignant biliary obstruction: a series of meta-analyses. Am J Gastroenterol 112:260–273

    Article  Google Scholar 

Download references

Acknowledgements

We appreciate the hard work of the colleagues at the database center of two hospitals who helped us reserve and search the relative data. Furthermore, we thank the Enago editing service.

Funding

This study was funded by Beijing Municipal Administration of Hospitals Incubating Program (Grant Number PX 2,020,047).

Author information

Authors and Affiliations

Authors

Contributions

As the leading principle investigator of the study, Professor WQ, LX contributed significantly to the study design and final approval of the article. YP contributed to data analysis and drafting of the manuscript. ZL, LSJ were responsible for analysis and interpretation of the data and critical revision of the article for important intellectual content. All authors provided significant input to the paper by means of revisions and all have read and approved the final manuscript.

Corresponding authors

Correspondence to Xun Li or Qi Wu.

Ethics declarations

Disclosures

Drs. Peng Yuan, Lei Zhang, Shijie Li, Xun Li, Qi Wu have no conflicts of interest or financial ties to disclose.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yuan, P., Zhang, L., Li, S. et al. Clinical results after biliary drainage by endoscopic retrograde cholangiopancreatography for analysis of metastatic cancer survival and prognostic factors. Surg Endosc 35, 6220–6226 (2021). https://doi.org/10.1007/s00464-020-08121-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00464-020-08121-2

Keywords

Navigation